Attendees during a lecture in a classroom at the UDST.
Doha: The University of Doha for Science and Technology (UDST) has announced the official approval of the ‘Pharmacy Technologist’ title and ‘Scope of Practice’ by the Department of Healthcare Professions, Ministry of Public Health (MoPH) in Qatar.
This milestone marks a significant advancement in empowering graduates of UDST’s Pharmacy Technology programme, reinforcing their role as vital contributors to the healthcare industry.
The innovative Scope of Practice has elevated the profession to new heights, showcasing the importance of pharmacy technology innovation on both national and global platforms.
UDST’s Bachelor of Science in Pharmacy Technology programme is the first of its kind locally, regionally, and internationally, offering specialised education and training in critical areas of pharmacy technology practice.
This cutting-edge programme integrates patient-focused learning with essential scientific disciplines, including drug discovery and development, pharmaceutical manufacturing, regulatory affairs, pharmacy informatics, quality assurance, drug compounding, and drug distribution for patient care.
These elements collectively prepare graduates to address evolving healthcare needs and contribute to the future of pharmacy practice.
Dr. Salem Al Naemi, President of the UDST, said, “This recognition reaffirms our dedication to providing world-class education and training that meets the highest global standards. By aligning with the Qatar National Vision 2030, we aim to support the development of a capable and innovative healthcare workforce in Qatar. Our Pharmacy Technology graduates are equipped with the skills and knowledge to lead advancements in healthcare, driving innovation, and ensuring the delivery of patient-centred care that addresses the nation’s evolving healthcare needs.”
The programme’s development aligns closely with the Qatar National Vision 2030, particularly its Human Development Pillar, which prioritises human capital development through enhanced education and healthcare.
Besides, the programme adheres to internationally recognised standards, drawing from the International Pharmaceutical Federation Development Goals, the National Association of Pharmacy Regulatory Authorities in Canada (NAPRA), the World Health Organisation (WHO) Guidelines: Norms and Standards for Pharmaceuticals, the European Competence Framework for Industrial Pharmacy Practice in Biotechnology, and the WHO Digital Health Strategy.
